198 related articles for article (PubMed ID: 36625077)
1. TREM2-dependent microglial function is essential for remyelination and subsequent neuroprotection.
Wang Y; Kyauk RV; Shen YA; Xie L; Reichelt M; Lin H; Jiang Z; Ngu H; Shen K; Greene JJ; Sheng M; Yuen TJ
Glia; 2023 May; 71(5):1247-1258. PubMed ID: 36625077
[TBL] [Abstract][Full Text] [Related]
2. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.
Cignarella F; Filipello F; Bollman B; Cantoni C; Locca A; Mikesell R; Manis M; Ibrahim A; Deng L; Benitez BA; Cruchaga C; Licastro D; Mihindukulasuriya K; Harari O; Buckland M; Holtzman DM; Rosenthal A; Schwabe T; Tassi I; Piccio L
Acta Neuropathol; 2020 Oct; 140(4):513-534. PubMed ID: 32772264
[TBL] [Abstract][Full Text] [Related]
3. Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model.
Beckmann N; Neuhaus A; Zurbruegg S; Volkmer P; Patino C; Joller S; Feuerbach D; Doelemeyer A; Schweizer T; Rudin S; Neumann U; Berth R; Frieauff W; Gasparini F; Shimshek DR
J Neuroinflammation; 2023 Feb; 20(1):29. PubMed ID: 36755323
[TBL] [Abstract][Full Text] [Related]
4. Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.
Beckmann N; Giorgetti E; Neuhaus A; Zurbruegg S; Accart N; Smith P; Perdoux J; Perrot L; Nash M; Desrayaud S; Wipfli P; Frieauff W; Shimshek DR
Acta Neuropathol Commun; 2018 Feb; 6(1):9. PubMed ID: 29448957
[TBL] [Abstract][Full Text] [Related]
5. TREM2 sustains microglial expansion during aging and response to demyelination.
Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
[TBL] [Abstract][Full Text] [Related]
6. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge.
Nugent AA; Lin K; van Lengerich B; Lianoglou S; Przybyla L; Davis SS; Llapashtica C; Wang J; Kim DJ; Xia D; Lucas A; Baskaran S; Haddick PCG; Lenser M; Earr TK; Shi J; Dugas JC; Andreone BJ; Logan T; Solanoy HO; Chen H; Srivastava A; Poda SB; Sanchez PE; Watts RJ; Sandmann T; Astarita G; Lewcock JW; Monroe KM; Di Paolo G
Neuron; 2020 Mar; 105(5):837-854.e9. PubMed ID: 31902528
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination.
Shen K; Reichelt M; Kyauk RV; Ngu H; Shen YA; Foreman O; Modrusan Z; Friedman BA; Sheng M; Yuen TJ
Cell Rep; 2021 Mar; 34(10):108835. PubMed ID: 33691116
[TBL] [Abstract][Full Text] [Related]
8. TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder.
You YF; Chen M; Tang Y; Yu WX; Pang XW; Chu YH; Zhang H; Shang K; Deng G; Zhou LQ; Yang S; Wang W; Xiao J; Tian DS; Qin C
J Neuroinflammation; 2023 Apr; 20(1):89. PubMed ID: 37013543
[TBL] [Abstract][Full Text] [Related]
9. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
10. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
Kawabori M; Kacimi R; Kauppinen T; Calosing C; Kim JY; Hsieh CL; Nakamura MC; Yenari MA
J Neurosci; 2015 Feb; 35(8):3384-96. PubMed ID: 25716838
[TBL] [Abstract][Full Text] [Related]
11. The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis.
Sen MK; Mahns DA; Coorssen JR; Shortland PJ
Glia; 2022 Jul; 70(7):1215-1250. PubMed ID: 35107839
[TBL] [Abstract][Full Text] [Related]
12. TREM2 regulates microglial cell activation in response to demyelination in vivo.
Cantoni C; Bollman B; Licastro D; Xie M; Mikesell R; Schmidt R; Yuede CM; Galimberti D; Olivecrona G; Klein RS; Cross AH; Otero K; Piccio L
Acta Neuropathol; 2015 Mar; 129(3):429-47. PubMed ID: 25631124
[TBL] [Abstract][Full Text] [Related]
13. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination.
Hwang M; Savarin C; Kim J; Powers J; Towne N; Oh H; Bergmann CC
J Neuroinflammation; 2022 Nov; 19(1):267. PubMed ID: 36333761
[TBL] [Abstract][Full Text] [Related]
14. TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination.
Gouna G; Klose C; Bosch-Queralt M; Liu L; Gokce O; Schifferer M; Cantuti-Castelvetri L; Simons M
J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34424266
[TBL] [Abstract][Full Text] [Related]
15. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
[TBL] [Abstract][Full Text] [Related]
16. TREM2 alleviates white matter injury after traumatic brain injury in mice might be mediated by regulation of DHCR24/LXR pathway in microglia.
Li Z; Yu S; Li L; Zhou C; Wang L; Tang S; Gu N; Zhang Z; Huang Z; Chen H; Tang W; Wang Y; Yang X; Sun X; Yan J
Clin Transl Med; 2024 Apr; 14(4):e1665. PubMed ID: 38649789
[TBL] [Abstract][Full Text] [Related]
17. TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration.
Xie M; Liu YU; Zhao S; Zhang L; Bosco DB; Pang YP; Zhong J; Sheth U; Martens YA; Zhao N; Liu CC; Zhuang Y; Wang L; Dickson DW; Mattson MP; Bu G; Wu LJ
Nat Neurosci; 2022 Jan; 25(1):26-38. PubMed ID: 34916658
[TBL] [Abstract][Full Text] [Related]
18. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG
Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.
Seyedsadr MS; Weinmann O; Amorim A; Ineichen BV; Egger M; Mirnajafi-Zadeh J; Becher B; Javan M; Schwab ME
Neurobiol Dis; 2019 Apr; 124():189-201. PubMed ID: 30468865
[TBL] [Abstract][Full Text] [Related]
20. Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency.
Reifschneider A; Robinson S; van Lengerich B; Gnörich J; Logan T; Heindl S; Vogt MA; Weidinger E; Riedl L; Wind K; Zatcepin A; Pesämaa I; Haberl S; Nuscher B; Kleinberger G; Klimmt J; Götzl JK; Liesz A; Bürger K; Brendel M; Levin J; Diehl-Schmid J; Suh J; Di Paolo G; Lewcock JW; Monroe KM; Paquet D; Capell A; Haass C
EMBO J; 2022 Feb; 41(4):e109108. PubMed ID: 35019161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
